Digital Angel Awarded U.S. Patent for Bio-Thermo(R) Implantable RFID (Temperature Sensing) Microchips
April 10 2006 - 8:30AM
PR Newswire (US)
First RFID Microchip to Determine Animal's Temperature Currently on
Sale in UK, Japan, and South Africa SO. ST. PAUL, Minn., April 10
/PRNewswire-FirstCall/ -- Digital Angel Corporation (AMEX:DOC), an
advanced technology company in the field of rapid and accurate
identification, location tracking, and condition monitoring of
high-value assets, announced today that the U.S. Patent and
Trademark Office has granted the Company a patent for its
Bio-Thermo(R) (temperature-sensing) implantable RFID microchip, a
syringe-implantable microchip designed for non-laboratory
applications that uses RFID technology to determine the body
temperature of its host animal. Potential applications for the
BioThermo chip include non-invasive monitoring of temperatures in
cats, dogs, livestock and horses and early detection of infectious
diseases such as Avian Bird Flu in poultry. Patents covering the
same Bio-Thermo RFID technology are also currently pending in
several other countries. The patented technology covers a passive
transponder, a sensor and integrated circuit that together make it
possible for someone with a scanner to determine the body
temperature of an animal implanted with the Bio-Thermo RFID
microchip. The Bio-Thermo microchips are currently being sold in
the companion pet market in the United Kingdom, Japan, and the
Philippines. The Company is currently in discussions with South
Africa, Israel and Australia as well. In the equine market the
Bio-Thermo microchips are currently being sold in South Africa and
the Company is currently in discussions with Japan as well. "The
Bio-Thermo microchip represents an important advance in the field
of animal health," said Digital Angel President and CEO Kevin N.
McGrath. "The technology allows veterinarians and animal owners to
quickly, simply and accurately monitor changes in the temperature
of an animal, which is often a reliable indicator of wellness. The
chips are already being well-received in markets around the world
and we look forward to introducing the chip in the pet and other
animal markets in the U.S." Digital Angel has begun marketing the
chips in the US equine market, and is preparing to launch sale of
the Bio-Thermo microchips for the US companion animal market. In
connection with planned launch for the companion animal market, the
Company is planning to sponsor a study to test and document the
correlation between the temperature measured by the subcutaneous
microchip with other common forms of temperature measurement. This
study is being discussed with the University of Minnesota College
of Veterinary Medicine. The patent, No. 7,015,826, was granted in
March and is titled "Method and Apparatus for Sensing and
Transmitting a Body Characteristic of a Host." About Digital Angel
Corporation Digital Angel Corporation develops and deploys sensor
and communications technologies that enable rapid and accurate
identification, location tracking, and condition monitoring of
high-value assets. Applications for the Company's products include
identification and monitoring of humans, pets, fish, poultry and
livestock through its patented implantable microchips; location
tracking and message monitoring of vehicles and aircraft in remote
locations through systems that integrate GPS and geosynchronous
satellite communications; and monitoring of asset conditions such
as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc.
(NASDAQ:ADSX). For more information about Digital Angel, please
visit http://www.digitalangelcorp.com/. The statements in this
press release that are not strictly historical, are
"forward-looking" statements within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 and are intended to be covered by the safe
harbors created by these sections. The forward-looking statements
are subject to risks and uncertainties and the actual results that
the Company achieves may differ materially from these
forward-looking statements due to such risks and uncertainties,
including, but not limited to, Applied Digital Inc. owns 55.4% of
the Company's common stock, new accounting pronouncements regarding
expensing of share based compensation may impact the Company's
future results of operations, the Company may continue to incur net
losses, infringement by third parties on the Company's intellectual
property or development of substantially equivalent proprietary
technology by the Company's competitors could negatively impact the
Company's business, domestic and foreign government regulation and
other factors could impair the Company's ability to develop and
sell its products in certain markets, the Company relies on sales
to government contractors for its animal identification and search
and rescue beacon products, and any decline in the demand by these
customers for such products could negatively affect the Company's
business, the Company depends on a single production arrangement
for its patented syringe-injectable microchips, and the loss of or
any significant reduction in the production could have an adverse
effect on the Company's business, technological change could cause
the Company's products to become obsolete, the loss of one of the
Company's principal customers could negatively impact the Company's
net revenue, the Company's earnings will decline if the Company
writes off goodwill and other intangible assts, options and
warrants outstanding and available for issuance may adversely
affect the market price of the Company's common stock, currency
exchange rate fluctuations could have an adverse effect on the
Company's sales and financial results, the Company depends on a
small team of senior management. A detailed statement of risks and
uncertainties is contained in the Company's reports to the
Securities and Exchange Commission, including in particular the
Company's Form 10-K for the fiscal year ended December 31, 2005.
Investors and stockholders are urged to read this document
carefully. The Company can offer no assurances that any
projections, assumptions or forecasts made or discussed in this
release will be met, and investors should understand the risks of
investing solely due to such projections. The Company undertakes no
obligation to revise any forward-looking statements in order to
reflect events or circumstances that may arise after the date of
this press release. Contact: Allen & Caron Inc Michael
Lucarelli (investors) Len Hall (media) 212-691-8087 949-474-4300
DATASOURCE: Digital Angel Corporation CONTACT: Investors, Michael
Lucarelli, +1-212-691-8087, , or Media, Len Hall, +1-949-474-4300,
, both of Allen & Caron Inc, for Digital Angel Corporation Web
site: http://www.digitalangelcorp.com/
Copyright
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Jul 2023 to Jul 2024